Thermo Fisher aims to sell parts of its diagnostics business for $4bn

Thermo Fisher plans to sell parts of diagnostics unit for US$4bil

KUALA LUMPUR: Thermo Fisher Scientific plans to sell its diagnostics unit for about US$4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people familiar with the matter. © New Straits Times Press (M) Bhd

Thermo Fisher aims to sell parts of its diagnostics business for $4bn

Deal would mark latest move by a life sciences group to jettison lower-growth assets

Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business

Biotechnology research firm Thermo Fisher Scientific is reportedly looking to sell part of its diagnostics business amid industrywide concerns about federal cutbacks in spending on research. [contact-form-7] The company’s advisers have been talking with private equity firms to assess potential buyers’ interest in the unit, seeking around $4 billion, the Financial Times (FT) reported Thursday (June 12), citing unnamed sources. There are …

Thermo Fisher Scientific Explores Diagnostics Exit Amid mRNA Expansion S&P 500

Highlights Thermo Fisher Scientific TMO plans to divest part of its diagnostics division Company expands mRNA innovation through a strategic collaboration with Ethris GmbH Stock price rises despite broader market volatility and global uncertainties Thermo Fisher Scientific (NYSE:TMO), a key player in the life sciences sector, has taken significant strategic steps amid shifting conditions in global markets. While broader indices such as the S&P …